Entry Point Capital, LLC Adma Biologics, Inc. Transaction History
Entry Point Capital, LLC
- $112 Billion
- Q1 2024
A detailed history of Entry Point Capital, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 4,740 shares of ADMA stock, worth $64,369. This represents 0.03% of its overall portfolio holdings.
Number of Shares
4,740Holding current value
$64,369% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
229Shares Held
175MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$247 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$143 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$142 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$106 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.67B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...